Skip to content
healthcare.dev

Selegiline Hydrochloride

NDC 72319-006, Selegiline Hydrochloride, tablet, from i3 Pharmaceuticals, LLC.

Product NDC
72319-006
Status
Listed
Labeler
i3 Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074672
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72319-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SELEGILINE HYDROCHLORIDE5 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]; Monoamine Oxidase Type B Inhibitor [EPC]; Monoamine Oxidase-B Inhibitors [MoA]

Package NDCNDC-11Package
72319-006-027231900060260 TABLET in 1 BOTTLE (72319-006-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c81e983b-455d-2e65-e053-2a95a90a3123
  • NADAC price for package 72319000602

    GET /v1/drugs/nadac/72319000602

Use it

Look up 72319-006 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72319-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72319-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.